# Pyridinobenzodiazepine payloads

Source: https://onco.cc/terms/pdd-payloads/  
OnCo record `pdd-payloads` (Term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

These experimental payloads are designed to damage selected DNA sequences. They are related to other DNA-binding payloads but have their own chemistry and evidence.

## Summary

Pyridinobenzodiazepines, or PDDs, are sequence-selective DNA mono-alkylators. A primary study linked a PDD monomer derivative to trastuzumab and reported activity in a pancreatic cancer xenograft model. The results support a preclinical payload concept. They do not establish a clinical advantage over TOP1 conjugates or justify assigning the crosslinking mechanism of PBD dimers to PDD monomers.

## Fields

- Kind: Term
- Last checked: 2026-11-08
- Also known as: PDD payloads; sequence-selective DNA mono-alkylating payloads

## Sources

- Andriollo et al., sequence-selective PDD payload (2025): https://doi.org/10.1039/d4md01040j

## Connected records

- terms: [DNA alkylator payloads](https://onco.cc/terms/dna-alkylator-payloads/), [DNA crosslinker payloads (PBD dimers)](https://onco.cc/terms/pbd-dimer-payloads/), [Indolinobenzodiazepine payloads](https://onco.cc/terms/ign-payloads/), [Next-generation antibody-conjugate payloads](https://onco.cc/terms/next-generation-adc-payloads/), [Payload (ADC)](https://onco.cc/terms/payload/)
- technologies: [Antibody-drug conjugate (ADC)](https://onco.cc/technologies/adc/)

---
JSON: https://onco.cc/api/v1/entities/pdd-payloads.json